Stay updated on FG-3019 in Diabetic Kidney Disease Clinical Trial
Sign up to get notified when there's something new on the FG-3019 in Diabetic Kidney Disease Clinical Trial page.

Latest updates to the FG-3019 in Diabetic Kidney Disease Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedUI updates include a Show glossary option, a revision/version notice, and capitalization tweaks to QC-related labels; these changes do not affect the core study information displayed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoChange DetectedSponsor changed from FibroGen to Kyntra Bio; page revision updated to v3.3.4.SummaryDifference0.2%

- Check47 days agoChange DetectedLocations were expanded to include state-by-state listings for Arizona, California, Georgia, Illinois, Kansas, Louisiana, Massachusetts, Michigan, Nebraska, New Jersey, New York, North Carolina, Ohio, Tennessee, Texas, Virginia, and Washington. The page also now shows Revision: v3.3.3, replacing v3.3.2.SummaryDifference2%

- Check68 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2. Core study details and page layout remain unchanged.SummaryDifference0.0%

- Check76 days agoChange DetectedA minor site revision label was added (v3.3.1) and the previous revision reference (v3.2.0) was removed. No study content or protocol details were changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedNotice about government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to FG-3019 in Diabetic Kidney Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 in Diabetic Kidney Disease Clinical Trial page.